Humana reported robust first-quarter 2026 revenue growth to $39.65 billion, yet saw a decrease in net income and diluted EPS. Despite the mixed financial results, the company's stock surged 23.3%, indicating a positive market reaction to other factors, possibly guidance or analyst expectations.
Humana Shares Surge 23% on Strong Q1 Revenue, Despite Lower EPS Guidance
HUMEarningsHealthcareQ1 ResultsRevenue Growth

